Use of soluble guanylate cyclase activators for treating acute and chronic lung diseases

Details for Australian Patent Application No. 2006299149 (hide)

Owner Bayer HealthCare AG

Inventors Thielemann, Wolfgang; Weimann, Gerrit; Stasch, Johannes-Peter; Krahn, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2006299149

PCT Pub. Number WO2007/039155

Priority 10 2005 047 946.4 06.10.05 DE

Filing date 23 September 2006

Wipo publication date 12 April 2007

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/195 (2006.01)

A61K 31/5377 (2006.01)

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/039155 Priority application(s): WO2007/039155

19 November 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299150-Sustained-release antimicrobial plastic composition with low rate of elution

2006299144-Cell populations having immunoregulatory activity, method for isolation and uses